Personalized cell transplant aims to keep leukemia at bay
NCT ID NCT00534469
Summary
This study tested a treatment to help prevent acute myeloid leukemia (AML) from returning after initial remission. For patients aged 60 or younger, doctors used high-dose chemotherapy and radiation to wipe out the bone marrow, then gave back the patient's own previously collected healthy stem cells to rebuild it. The goal was to see if this intensive procedure, followed by a drug to boost the immune system, could improve long-term survival without the cancer coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.